Vext Science, Inc. (CSE:VEXT)
Canada · Delayed Price · Currency is CAD 0.2500
-0.0100 (-3.85%)
Jun 1, 2026, 3:59 PM EST
Vext Science Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 51.97 | 51.37 | 36 | 34.81 | 35.41 | 37.24 | |
Revenue Growth (YoY) | 32.67% | 42.69% | 3.41% | -1.69% | -4.92% | 47.83% |
Cost of Revenue | 34.27 | 36.91 | 27.02 | 22.77 | 12.31 | 20.81 |
Gross Profit | 17.7 | 14.46 | 8.98 | 12.04 | 23.1 | 16.43 |
Selling, General & Admin | 16 | 14.92 | 14.29 | 13.46 | 8.37 | 5.24 |
Amortization of Goodwill & Intangibles | 5.93 | 5.8 | 5.47 | 4.85 | 3.33 | 0.86 |
Other Operating Expenses | - | - | - | -0.02 | 0.01 | 1.22 |
Operating Expenses | 22.61 | 21.4 | 20.16 | 19.86 | 13.83 | 8.44 |
Operating Income | -4.91 | -6.94 | -11.18 | -7.82 | 9.27 | 7.99 |
Interest Expense | -4.43 | -4.48 | -3.93 | -3.81 | -2.04 | -1.01 |
Interest & Investment Income | 0.16 | 0.18 | 0.22 | 0.16 | 0.11 | 0.74 |
Earnings From Equity Investments | - | - | -3.65 | 1.93 | -0.47 | -0.54 |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | 0 | -0.01 | 0 | -0.01 |
Other Non Operating Income (Expenses) | 1.19 | 0.55 | -1.94 | - | - | 0.08 |
EBT Excluding Unusual Items | -8.01 | -10.7 | -20.47 | -9.55 | 6.88 | 7.24 |
Impairment of Goodwill | -3.07 | -3.07 | - | - | - | - |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.43 |
Gain (Loss) on Sale of Assets | - | - | - | -0.81 | 0.02 | 0 |
Asset Writedown | -1.95 | -1.95 | - | - | - | - |
Other Unusual Items | 0.73 | 0.51 | -0.65 | 13.72 | -0.2 | - |
Pretax Income | -12.3 | -15.21 | -21.12 | 3.36 | 6.7 | 6.82 |
Income Tax Expense | 3.25 | 2.78 | 1.31 | -1.04 | -4.22 | 1.83 |
Net Income | -15.55 | -17.99 | -22.44 | 4.4 | 10.92 | 4.99 |
Net Income to Common | -15.55 | -17.99 | -22.44 | 4.4 | 10.92 | 4.99 |
Net Income Growth | - | - | - | -59.72% | 118.97% | 134.66% |
Shares Outstanding (Basic) | 248 | 248 | 241 | 164 | 139 | 137 |
Shares Outstanding (Diluted) | 248 | 248 | 241 | 165 | 140 | 146 |
Shares Change (YoY) | 0.46% | 2.77% | 46.24% | 18.06% | -4.70% | 56.55% |
EPS (Basic) | -0.06 | -0.07 | -0.09 | 0.03 | 0.08 | 0.04 |
EPS (Diluted) | -0.06 | -0.07 | -0.09 | 0.03 | 0.08 | 0.03 |
EPS Growth | - | - | - | -66.00% | 162.14% | 49.99% |
Free Cash Flow | 7.07 | 8.15 | 1.82 | 1.69 | -3.14 | -7.53 |
Free Cash Flow Per Share | 0.03 | 0.03 | 0.01 | 0.01 | -0.02 | -0.05 |
Gross Margin | 34.06% | 28.14% | 24.94% | 34.58% | 65.23% | 44.12% |
Operating Margin | -9.45% | -13.51% | -31.06% | -22.48% | 26.18% | 21.45% |
Profit Margin | -29.93% | -35.03% | -62.32% | 12.63% | 30.84% | 13.39% |
Free Cash Flow Margin | 13.61% | 15.86% | 5.07% | 4.85% | -8.86% | -20.21% |
EBITDA | 9.99 | 7.98 | 3.22 | 1.54 | 15.52 | 11.25 |
EBITDA Margin | 19.23% | 15.54% | 8.94% | 4.42% | 43.84% | 30.20% |
D&A For EBITDA | 14.91 | 14.92 | 14.4 | 9.36 | 6.25 | 3.26 |
EBIT | -4.91 | -6.94 | -11.18 | -7.82 | 9.27 | 7.99 |
EBIT Margin | -9.45% | -13.51% | -31.06% | -22.48% | 26.18% | 21.45% |
Effective Tax Rate | - | - | - | - | - | 26.88% |
Revenue as Reported | 51.97 | 51.37 | 36 | - | - | - |